Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19.
Medicina (Kaunas)
; 57(10)2021 Sep 28.
Article
in English
| MEDLINE | ID: covidwho-1444269
ABSTRACT
In some subjects with inherited pheochromocytoma/paraganglioma (PPG) syndromes, hypoxia-inducible factor 1 alpha (HIF1α) stabilization/activation could lead to an increase in angiotensin converting enzymes (ACE). This would result in the stimulation of angiotensin (AT) II production and, hence, reduce the availability of ACE 2. The latter would provide decreased numbers of binding sites for the spike protein of SARS-CoV-2 and, therefore, result in less points of viral entry into cells. Thus, subjects with HIF1α-associated PPG syndromes may benefit from an inherent protective effect against COVID-19. Such an implication of HIF1α vis-à-vis COVID-19 could open ways of therapeutic interventions.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Paraganglioma
/
Pheochromocytoma
/
Adrenal Gland Neoplasms
/
COVID-19
Limits:
Humans
Language:
English
Journal subject:
Medicine
Year:
2021
Document Type:
Article
Affiliation country:
Medicina57101033
Similar
MEDLINE
...
LILACS
LIS